Pleasanton Weekly

News - March 21, 2014

Thoratec issues heart device warning after 4 deaths

Pleasanton company says problems involve system controller

by Jeb Bing

Thoratec Corp. of Pleasanton has initiated a voluntary worldwide "medical device correction" in order to update its labeling and training materials for its HeartMate II LVAS Pocket System Controller.

The safety advisory was issued because some patients and caregivers had experienced difficulties with the process of changing from a primary system controller to their backup system controller. Those difficulties resulted in four deaths and five reports of loss of consciousness or other symptoms of hypoperfusion.

"Failure to completely connect the driveline during the process of exchanging Pocket System Controllers has resulted in serious injuries and deaths," a Thoratec spokesman said.

"Patients who received the Pocket Controller as a replacement for an older model (EPC System Controller) may be at a higher risk of experiencing difficulty in the controller exchange process, as there are differences between the two controller models, especially differences related to the connection of the driveline," the spokesman added.

As of Feb. 4, the rate of serious injury or death during the process of controller exchange for patients who converted to the Pocket Controller from the EPC Controller was 1.5%, while the rate for patients who received the Pocket Controller at the time of implant was 0.1%.

Of the nine incidents, eight occurred in patients who were converted to the Pocket Controller after being originally trained on the older EPC System Controller. Two of the deaths occurred in patients who attempted to exchange system controllers while alone and, contrary to the labeling, without contacting the hospital first.

The "Urgent Medical Device Correction Letter" sent to hospitals on March 4 communicated the reported incident rate over the past year and a half since the introduction of the Pocket System Controller in August 2012.

Thoratec said its investigations of these reports have not revealed any failures of the devices to meet specifications or deficiencies in quality control procedures. No product needs to be returned to Thoratec.

Consumers who have the HeartMate II LVAS Pocket Controller should immediately contact their doctor for retraining on use of the device and to receive updated "Patient Handbook" information.

The company also urged physicians who prescribe the Pocket Controller to review the updated labeling and training materials provided in the Urgent Medical Device Correction Letter with all clinical personnel responsible for training patients and caregivers on the use of the Pocket System Controller.

Clinicians and patients with questions may contact the company at 1-800-528-2577, or if calling from outside the USA, 1-925-847-8600 (seven days a week, 8 a.m. to 5 p.m. Pacific Daylight Time).

Comments

There are no comments yet for this post

Don't miss out on the discussion!
Sign up to be notified of new comments on this topic.

Email:


Post a comment

Posting an item on Town Square is simple and requires no registration. Just complete this form and hit "submit" and your topic will appear online. Please be respectful and truthful in your postings so Town Square will continue to be a thoughtful gathering place for sharing community information and opinion. All postings are subject to our TERMS OF USE, and may be deleted if deemed inappropriate by our staff.

We prefer that you use your real name, but you may use any "member" name you wish.

Name: *

Select your neighborhood or school community: *

Choose a category: *

Since this is the first comment on this story a new topic will also be started in Town Square! Please choose a category that best describes this story.

Comment: *

Verification code: *
Enter the verification code exactly as shown, using capital and lowercase letters, in the multi-colored box.

*Required Fields